Menarini said the test, which detects IgG and IgM antibodies, is available in the US based on receipt of an FDA EUA by its manufacturer, Healgen Scientific.
Medusa19, with an initial focus on home testing, is investing in a global e-commerce infrastructure to prepare for the launch of Avacta’s COVID-19 rapid test.